These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 25567000
1. Tubular carcinoma of the breast: institutional and SEER database analysis supporting a unique classification. Romano AM, Wages NA, Smolkin M, Fortune KL, Atkins K, Dillon PM. Breast Dis; 2015; 35(2):103-11. PubMed ID: 25567000 [Abstract] [Full Text] [Related]
2. Is there a low-grade precursor pathway in breast cancer? King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M. Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747 [Abstract] [Full Text] [Related]
3. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer. Cefaro GA, Genovesi D, Trignani M, DI Nicola M. Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361 [Abstract] [Full Text] [Related]
4. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres. Angarita FA, Chesney T, Elser C, Mulligan AM, McCready DR, Escallon J. Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372 [Abstract] [Full Text] [Related]
5. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran. Amirifard N, Sadeghi E. Asian Pac J Cancer Prev; 2016 May; 17(5):2593-6. PubMed ID: 27268636 [Abstract] [Full Text] [Related]
6. Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004. Kinoshita T, Fukui N, Anan K, Iwamoto T, Niikura N, Kawai M, Hayashi N, Tsugawa K, Aogi K, Ishida T, Masuoka H, Masuda S, Iijima K, Nakamura S, Tokuda Y. Breast Cancer; 2016 Jan; 23(1):39-49. PubMed ID: 26446041 [No Abstract] [Full Text] [Related]
7. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications]. Modesto A, Gandy C, Mery E, Filleron T, Massabeau C, Izar F, Charitansky H, Roché H, de Lafontan B. Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020 [Abstract] [Full Text] [Related]
8. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ, Panel Members. Ann Oncol; 2015 Aug; 26(8):1533-46. PubMed ID: 25939896 [Abstract] [Full Text] [Related]
9. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH. Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696 [Abstract] [Full Text] [Related]
10. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma. Wong SM, Freedman RA, Sagara Y, Stamell EF, Desantis SD, Barry WT, Golshan M. Cancer; 2015 Dec 15; 121(24):4333-40. PubMed ID: 26376021 [Abstract] [Full Text] [Related]
11. Overview of breast cancer. Watkins EJ. JAAPA; 2019 Oct 15; 32(10):13-17. PubMed ID: 31513033 [Abstract] [Full Text] [Related]
12. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys. Cutuli B, Dalenc F, Cottu PH, Gligorov J, Guastalla JP, Petit T, Amrate A. Cancer Radiother; 2015 Aug 15; 19(5):295-302. PubMed ID: 26188735 [Abstract] [Full Text] [Related]
13. Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution. Cortadellas T, Córdoba O, Gascón A, Haladjian C, Bernabeu A, Alcalde A, Esgueva A, Rodriguez-Revuelto R, Espinosa-Bravo M, Díaz-Botero S, Xercavins J, Rubio IT, Gil-Moreno A. Eur J Surg Oncol; 2015 May 15; 41(5):635-40. PubMed ID: 25703077 [Abstract] [Full Text] [Related]
14. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, Miyamoto K, Yamamoto Y, Iwase T. Breast Cancer; 2010 Apr 15; 17(2):118-24. PubMed ID: 19466512 [Abstract] [Full Text] [Related]
15. Tubular carcinoma and grade 1 (well-differentiated) invasive ductal carcinoma: comparison of flat epithelial atypia and other intra-epithelial lesions. Kunju LP, Ding Y, Kleer CG. Pathol Int; 2008 Oct 15; 58(10):620-5. PubMed ID: 18801081 [Abstract] [Full Text] [Related]
16. Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review. Di Lascio S, Tognazzo E, Bigiotti S, Bonollo M, Costa A, Pagani O, Meani F. Eur J Surg Oncol; 2021 Apr 15; 47(4):796-803. PubMed ID: 33097334 [Abstract] [Full Text] [Related]
17. Hormone receptor-negative breast cancer: undertreatment of patients over 80. Weiss A, Noorbakhsh A, Tokin C, Chang D, Blair SL. Ann Surg Oncol; 2013 Oct 15; 20(10):3274-8. PubMed ID: 23838924 [Abstract] [Full Text] [Related]
18. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China. Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM. Ann Surg Oncol; 2012 Sep 15; 19(9):3019-27. PubMed ID: 22451233 [Abstract] [Full Text] [Related]
19. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade? Banz-Jansen C, Heinrichs A, Hedderich M, Waldmann A, Wedel B, Mebes I, Diedrich K, Rody A, Fischer D. Arch Gynecol Obstet; 2013 Aug 15; 288(2):379-83. PubMed ID: 23407999 [Abstract] [Full Text] [Related]
20. Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era. Nye L, Rademaker A, Gradishar WJ. Clin Breast Cancer; 2017 Jul 15; 17(4):e185-e189. PubMed ID: 28185739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]